We used the HCT116 colorectal carcinoma cell line that has low levels of IGF2BP1, but high IGF2BP2 expression (Mongroo et al. 2011; Nusinow et al. 2020; Lu et al. 2021). This evidence concerns the gene IGF2BP2 and colorectal carcinoma.